Pediatric Neurogenic Bladder Cases Are Not Fully Evaluated
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 3, 2023 -- Pediatric neurogenic bladder (NGB) cases are not fully evaluated in routine clinical practice, according to a study published online Oct. 16 in Advances in Therapy.
Naoko Izumi, from Pfizer Japan in Tokyo, and colleagues conducted a retrospective cohort study involving patients aged 17 years and younger with NGB to examine the current status of NGB management over a 24-month follow-up. Data were included for 883 eligible children, including 39.3 percent with spina bifida.
The researchers found that renal urinary tract ultrasound and urinalysis were performed at least once in >35 and >45 percent of patients over 12-/24-month post-index periods, respectively, while substantially fewer patients underwent specific tests (urodynamics, cystourethrography, scintigraphy; <11/<13 percent). Overactive bladder medications were used by 21.5 percent of patients over 24 months, and 10.8 percent of patients underwent clean intermittent catheterization (CIC) alone or with medications; 1.2 percent underwent surgery. The most common incident complications were lower urinary tract infection (UTI), urinary incontinence, and hydronephrosis (23.2, 9.7, and 7.0 percent, respectively). In an analysis of risk factors for UTI, significantly higher odds ratios were seen for CIC, presence of spina bifida, and constipation (5.70, 2.86, and 2.07, respectively). There was inadequate performance of urodynamic assessments overall.
"Our present study shows that NGB cases are not fully evaluated in routine clinical practice, both for diagnostic and follow-up purposes, despite clear directions provided by the guidelines," the authors write. "This may hamper the ongoing management of these patients and adversely affect the outcomes."
The study was funded by Pfizer Japan.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Factors ID'd for Clean Intermittent Catheterization Compliance in Youth With Neurogenic Bladder
WEDNESDAY, May 8, 2024 -- For children with neurogenic bladder, self-catheterization is associated with lower adherence to clean intermittent catheterization (CIC), according to a...
Transcutaneous Tibial Nerve Stimulation Device Beneficial in Overactive Bladder
TUESDAY, April 2, 2024 -- For patients with overactive bladder (OAB) symptoms, a wearable, smartphone-controlled, rechargeable transcutaneous tibial nerve stimulation (TTNS)...
Multicomponent Intervention Aids Quality of Life With Overactive Bladder
FRIDAY, March 22, 2024 -- A multicomponent intervention improves health-related quality of life (HRQOL) for women with moderate-to-severe overactive bladder, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.